Oligonucleotide compositions and methods thereof
Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.
1. A method for characterizing a chirally controlled oligonucleotide composition, the method comprising:
assessing complement activation by the chirally controlled oligonucleotide composition relative to a reference oligonucleotide composition;
wherein:
the chirally controlled oligonucleotide composition comprises a plurality of oligonucleotides of a particular oligonucleotide type which are structurally identical;
which composition is chirally controlled in that it is enriched, relative to a substantially racemic preparation of oligonucleotides of the particularly oligonucleotide type, for oligonucleotides of the particular oligonucleotide type;
oligonucleotides of the plurality comprises 5 or more phosphorothioate internucleotidic linkages, wherein at least about 50% phosphorothioate internucleotidic linkages are Sp;
the reference oligonucleotide composition is a substantially racemic preparation of oligonucleotides of the particularly type; and
wherein the reference oligonucleotide composition increases complement activation compared to absence of the reference oligonucleotide composition.
2. The method of claim 1 , wherein the pattern of backbone chiral centers comprise at least one Rp and at least one Sp.
3. The method of claim 2 , wherein the pattern of backbone chiral centers comprise Rp(Sp)m, wherein m is 2, 3, 4, 5, 6, 7 or 8.
4. The method of claim 3 , wherein the pattern of backbone chiral centers comprise RpSpSp.
5. The method of claim 4 , wherein the pattern of backbone chiral centers comprise (Np)t(Rp)(Sp)m, wherein t is 1-10, m is 2, 3, 4, 5, 6, 7 or 8, and each Np is independent Rp or Sp.
6. The method of claim 5 , wherein the pattern of backbone chiral centers comprise SpRpSpSp.
7. The method of claim 3 , wherein oligonucleotides of the first plurality comprise one or more natural phosphate linkages.
8. The method of claim 1 , wherein the method comprises assessing level of C3a.
9. The method of claim 1 , wherein the method comprises assessing level of Bb.